Form 4: Revvity Director Acquires Restricted Stock Units

Revvity, Inc. Director Sophie V. Vandebroek acquired restricted stock units, with vesting contingent on continued service and subject to specific change-in-control provisions.

Summary

• Sophie V. Vandebroek, a Director at Revvity, Inc., was granted restricted stock units (RSUs) on May 7, 2026.
• Each RSU represents a contingent right to receive one share of Revvity's common stock.
• The RSUs are scheduled to fully vest on April 27, 2027, coinciding with the issuer's next annual shareholder meeting.
• Vesting is contingent upon Ms. Vandebroek's continued service through the vesting date.
• Vesting may also occur earlier upon the Reporting Person's death, disability, or qualifying retirement.
• Additionally, vesting will occur upon the termination of service within 12 months following a change in control of the company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard equity grant to a director as part of their compensation package, rather than a significant personal investment or divestment.

Positives

• Director acquisition of equity aligns incentives with shareholders.
• Vesting schedule tied to continued service encourages long-term commitment.
• Provisions for early vesting upon death, disability, or change in control offer security to the director.

Negatives

• The acquisition is a grant of RSUs, not an open market purchase, indicating it's part of compensation rather than an investment conviction.
• Vesting is contingent, meaning the shares are not yet fully owned by the director.

Risks

• The value of the RSUs is subject to the future performance of Revvity's stock price.
• Vesting is contingent on continued service, meaning the director could forfeit the RSUs if service is terminated before vesting.
• A change in control event could trigger early vesting, but the specifics of such a change are not detailed.

Future Outlook

The future outlook for the restricted stock units is tied to the company's performance and the director's continued service. Vesting is scheduled for April 27, 2027, with potential earlier vesting under specific circumstances like death, disability, qualifying retirement, or a change in control.

Industry Context

StockSavvy.ai notes that grants of restricted stock units to directors are a common form of executive compensation across the life sciences and technology sectors, designed to retain talent and align their interests with shareholders. The specific vesting conditions are typical for such grants.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director is a form of compensation, which impacts dilution. However, the vesting tied to service and performance aims to benefit shareholders through director retention and alignment.
• Employees: This filing does not directly impact employees, but it is part of the broader compensation structure for key personnel.
• Management: The filing details a compensation event for a member of the board of directors.

Next Steps

• Ms. Vandebroek is expected to continue her service as Director through the vesting date of April 27, 2027, for the RSUs to vest.
• The company may experience a change in control, which would trigger early vesting of the RSUs.
• The company will hold its next annual shareholder meeting on or around April 27, 2027.

Key Dates

Keywords

Revvity, RVTY, Form 4, Insider Trading, Restricted Stock Units, RSU, Director, Stock Options, Equity Grant, Beneficial Ownership, Vesting Schedule, Change in Control